Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_assertion type Assertion NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_head.
- NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_assertion description "[In the present study, we genetically engineered human blood-derived endothelial colony-forming cells (ECFCs) to express erythropoietin (EPO) under the control of a tetracycline-regulated system, and generated subcutaneous vascular networks capable of systemic EPO release in immunodeficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_provenance.
- NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_assertion evidence source_evidence_literature NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_provenance.
- NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_assertion SIO_000772 21937702 NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_provenance.
- NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_assertion wasDerivedFrom befree-2016 NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_provenance.
- NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_assertion wasGeneratedBy ECO_0000203 NP925579.RAOMrgtoybWgZeoiihl62sPOZFuvU50QH-TWO9IlvinlI130_provenance.